Inborn errors of STAT1 immunity

Boisson-Dupuis, 2012, Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes, Curr Opin Immunol, 24, 364, 10.1016/j.coi.2012.04.011 Chen, 1998, Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA, Cell, 93, 827, 10.1016/S0092-8674(00)81443-9 Dupuis, 2003, Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency, Nat Genet, 33, 388, 10.1038/ng1097 Sakata, 2020, Autosomal recessive complete STAT1 deficiency caused by compound heterozygous intronic mutations, Int Immunol, 32, 663, 10.1093/intimm/dxaa043 Boehmer, 2020, A novel complete autosomal-recessive STAT1 LOF variant causes immunodeficiency with hemophagocytic lymphohistiocytosis-like hyperinflammation, J Allergy Clin Immunol Pract, 8, 3102, 10.1016/j.jaip.2020.06.034 Vairo, 2011, Severe impairment of IFN-gamma and IFN-alpha responses in cells of a patient with a novel STAT1 splicing mutation, Blood, 118, 1806, 10.1182/blood-2011-01-330571 Karakawa, 2021, Successful hematopoietic stem cell transplantation for autosomal recessive STAT1 complete deficiency, J Clin Immunol, 1 Chapgier, 2009, A partial form of recessive STAT1 deficiency in humans, J Clin Invest, 119, 1502, 10.1172/JCI37083 Kong, 2010, A novel form of human STAT1 deficiency impairing early but not late responses to interferons, Blood, 116, 5895, 10.1182/blood-2010-04-280586 Kristensen, 2011, Novel STAT1 alleles in a patient with impaired resistance to mycobacteria, J Clin Immunol, 31, 265, 10.1007/s10875-010-9480-8 Bustamante, 2020, Mendelian susceptibility to mycobacterial disease: recent discoveries, Hum Genet, 139, 993, 10.1007/s00439-020-02120-y Kerner, 2020, Inherited human IFN-gamma deficiency underlies mycobacterial disease, J Clin Invest, 130, 3158, 10.1172/JCI135460 Yang, 2020, Human T-bet governs innate and innate-like adaptive IFN-gamma immunity against mycobacteria, Cell, 183, 1826, 10.1016/j.cell.2020.10.046 Dupuis, 2001, Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation, Science, 293, 300, 10.1126/science.1061154 Chapgier, 2006, Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease, PLoS Genet, 2, 10.1371/journal.pgen.0020131 Sampaio, 2012, A novel STAT1 mutation associated with disseminated mycobacterial disease, J Clin Immunol, 32, 681, 10.1007/s10875-012-9659-2 Tsumura, 2012, Dominant-negative STAT1 SH2 domain mutations in unrelated patients with Mendelian susceptibility to mycobacterial disease, Hum Mutat, 33, 1377, 10.1002/humu.22113 Hirata, 2013, Heterozygosity for the Y701C STAT1 mutation in a multiplex kindred with multifocal osteomyelitis, Haematologica, 98, 1641, 10.3324/haematol.2013.083741 Kagawa, 2017, Alanine-scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants, J Allergy Clin Immunol, 140, 232, 10.1016/j.jaci.2016.09.035 Ueki, 2017, A heterozygous dominant-negative mutation in the coiled-coil domain of STAT1 is the cause of autosomal-dominant Mendelian susceptibility to mycobacterial diseases, Clin Immunol, 174, 24, 10.1016/j.clim.2016.11.004 Ying, 2019, Current status of the management of Mendelian susceptibility to mycobacterial disease in mainland China, J Clin Immunol, 39, 600, 10.1007/s10875-019-00672-x Puel, 2011, Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity, Science, 332, 65, 10.1126/science.1200439 Liu, 2011, Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis, J Exp Med, 208, 1635, 10.1084/jem.20110958 van de Veerdonk, 2011, STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis, N Engl J Med, 365, 54, 10.1056/NEJMoa1100102 Takezaki, 2012, Chronic mucocutaneous candidiasis caused by a gain-of-function mutation in the STAT1 DNA-binding domain, J Immunol, 189, 1521, 10.4049/jimmunol.1200926 Smeekens, 2011, STAT1 hyperphosphorylation and defective IL12R/IL23R signaling underlie defective immunity in autosomal dominant chronic mucocutaneous candidiasis, PLoS One, 6, 10.1371/journal.pone.0029248 Okada, 2020, Human STAT1 gain-of-function heterozygous mutations: chronic mucocutaneous candidiasis and type I interferonopathy, J Clin Immunol, 40, 1065, 10.1007/s10875-020-00847-x Erdos, 2020, Recurrent, severe aphthous stomatitis and mucosal ulcers as primary manifestations of a novel STAT1 gain-of-function mutation, Front Immunol, 11, 967, 10.3389/fimmu.2020.00967 Toubiana, 2016, Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype, Blood, 127, 3154, 10.1182/blood-2015-11-679902 Vargas-Hernandez, 2018, Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations, J Allergy Clin Immunol, 141, 2142, 10.1016/j.jaci.2017.08.040 Bloomfield, 2018, Utility of ruxolitinib in a child with chronic mucocutaneous candidiasis caused by a novel STAT1 gain-of-function mutation, J Clin Immunol, 38, 589, 10.1007/s10875-018-0519-6 Zimmerman, 2017, Risks of ruxolitinib in STAT1 gain-of-function-associated severe fungal disease, Open Forum Infect Dis, 4, 10.1093/ofid/ofx202 Higgins, 2015, Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation, J Allergy Clin Immunol, 135, 551, 10.1016/j.jaci.2014.12.1867 Weinacht, 2017, Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation, J Allergy Clin Immunol, 139, 1629, 10.1016/j.jaci.2016.11.022 Forbes, 2018, Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations, J Allergy Clin Immunol, 142, 1665, 10.1016/j.jaci.2018.07.020 Mössner, 2016, Ruxolitinib induces interleukin 17 and ameliorates chronic mucocutaneous candidiasis caused by STAT1 gain-of-function mutation, Clin Infect Dis, 62, 951, 10.1093/cid/ciw020 Tangye, 2020, Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee, J Clin Immunol, 40, 24, 10.1007/s10875-019-00737-x